PRRX1 and cancer: Altogether, these results indicate that similar to PRRX1, when miR-15 are expressed at high levels in cancer patients, they are associated with better prognosis, even in patients who have the cancer spread to their lymph nodes and also in basal/TNBC subtype which comprises the most unfavorable disease.